| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Escherichia coli (EC14 + Turbidity) |
- |
- |
1 － ? |
Tobramycin (Tobrex, Nebcin)  |
889 |
| Escherichia coli (EC14 + Turbidity) |
- |
- |
4 － ? |
Kanamycin (Kantrex) |
889 |
| Escherichia coli (EC14 + Turbidity) |
- |
- |
8 － ? |
Chloramphenicol (Chloromycetin) |
889 |
| Escherichia coli (enteroaggregative) |
<0.06 |
<0.06 |
? － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
491 |
| Escherichia coli (enteroaggregative) |
<0.06 |
<0.06 |
? － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
62 |
| Escherichia coli (enteroaggregative) |
4 |
16 |
? － ? |
Nalidixic acid (NegGam) |
62 |
| Escherichia coli (enteroaggregative) |
4 |
16 |
? － ? |
Nalidixic acid (NegGam) |
491 |
| Escherichia coli (enteroaggregative) |
8 |
16 |
? － ? |
Rifampicin (Rifampin) |
491 |
| Escherichia coli (enteroaggregative) |
8 |
16 |
? － ? |
Rifampicin (Rifampin) |
62 |
| Escherichia coli (enteroaggregative) |
8 |
16 |
? － ? |
Rifaximin (Xifaxan) |
491 |
| Escherichia coli (enteroaggregative) |
8 |
16 |
? － ? |
Rifaximin (Xifaxan) |
62 |
| Escherichia coli (enteroaggregative) |
>16 |
>128 |
? － ? |
Trimethoprim (Proloprim, Trimpex) |
491 |
| Escherichia coli (enteroaggregative) |
>16 |
>128 |
? － ? |
Trimethoprim (Proloprim, Trimpex) |
62 |
| Escherichia coli (enteroaggregative) |
>32 |
>128 |
? － ? |
Chloramphenicol (Chloromycetin) |
491 |
| Escherichia coli (enteroaggregative) |
>32 |
>128 |
? － ? |
Chloramphenicol (Chloromycetin) |
62 |
| Escherichia coli (enteroaggregative) |
>128 |
>128 |
? － ? |
Ampicillin (Omnipen) |
491 |
| Escherichia coli (enteroaggregative) |
>128 |
>128 |
? － ? |
Ampicillin (Omnipen) |
62 |
| Escherichia coli (enteroaggregative) |
>128 |
>128 |
? － ? |
Tetracycline (Sumycin, Achromycin V, Steclin) |
62 |
| Escherichia coli (enteroaggregative) |
>128 |
>128 |
? － ? |
Tetracycline (Sumycin, Achromycin V, Steclin) |
491 |
| Escherichia coli (enteroaggregative) |
- |
- |
≤0.0156 － ? |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
478 |
| Escherichia coli (enteroaggregative) |
- |
- |
0.0312 － ? |
Ceftriaxone (Rocephin) |
478 |
| Escherichia coli (enteroaggregative) |
- |
- |
0.25 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
478 |
| Escherichia coli (enteroaggregative) |
- |
- |
1 － ? |
Levofloxacin (Levaquin, Quixin) |
478 |
| Escherichia coli (enteroaggregative) |
- |
- |
16 － ? |
Mecillinam (Amdinocillin) |
478 |
| Escherichia coli (enteroaggregative) |
- |
- |
32 － ? |
Rifaximin (Xifaxan) |
478 |
| Escherichia coli (enteroaggregative) |
- |
- |
64 － ? |
Doxycycline (Doxycycline hyclate, Doxy, Vibra, Vibramycin) |
478 |
| Escherichia coli (enteroaggregative) |
- |
- |
128 － ? |
Nalidixic acid (NegGam) |
478 |
| Escherichia coli (enteroaggregative) |
- |
- |
1024 － ? |
Ampicillin (Omnipen) |
478 |